- Benign Prostatic Hyperplasia
- Hormone Therapy
- Genomic Testing
- Next-Generation Imaging
- UTUC
- OAB and Incontinence
- Genitourinary Cancers
- Kidney Cancer
- Men's Health
- Pediatrics
- Female Urology
- Sexual Dysfunction
- Kidney Stones
- Urologic Surgery
- Bladder Cancer
- Benign Conditions
- Prostate Cancer
Survey to examine patterns of prostate cancer survivorship care
The anonymous online survey, is meant to gain information “from urologists about the current survivorship care that is provided for survivors of prostate cancer,” according to Stacy Loeb, MD, MSc.
A recently launched survey is looking to evaluate patterns of prostate cancer survivorship care among providers who manage patients with prostate cancer.
Discussing the impetus behind the survey, Stacy Loeb, MD, MSc, told Urology Times®, “There are more than 3 million prostate cancer survivors living in the United States. Prostate cancer has a significant impact on quality of life, including urinary health, sexual function, and overall well-being.”
The anonymous online survey, which Loeb said can be completed in approximately 5 minutes, is meant to gain information “from urologists about the current survivorship care that is provided for survivors of prostate cancer,” according to Loeb, professor of urology and population health at New York University Grossman School of Medicine, New York City.
Added Loeb, “Once the survey is completed, we will publish the results in a urology journal and disseminate them through social media. We will also use the information to identify gaps that we can address to improve future care for prostate cancer.”
To take the survey, click here
Cell-cycle risk score is predictive of ADT benefit in prostate cancer
May 17th 2024"Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk of death is for a man on surveillance," says Jonathan D. Tward, MD, PhD.
